These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 380780)

  • 41. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
    Hyman AL; Kadowitz PJ
    Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple control of fever production in the central nervous system of rabbits.
    Morimoto A; Murakami N; Nakamori T; Watanabe T
    J Physiol; 1988 Mar; 397():269-80. PubMed ID: 3261794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandins activation of erythropoietin production and erythroid progenitor cells.
    Fisher JW; Radtke HW; Jubiz W; Nelson PK; Burdowski A
    Exp Hematol; 1980; 8 Suppl 8():65-89. PubMed ID: 6761139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation.
    Williams TJ
    Br J Pharmacol; 1979 Mar; 65(3):517-24. PubMed ID: 371730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The involvement of methysergide-sensitive receptors and prostaglandins in the hyperthermia evoked by 5-HT in the cat.
    Komiskey HL; Rudy TA
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):195-208. PubMed ID: 1153868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body temperature of rats after prostaglandins E2 and F2 alpha and their precursor.
    Spławiński J; Wojtaszek B; Górka Z
    Pharmacol Biochem Behav; 1981 Oct; 15(4):657-8. PubMed ID: 6794041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostacyclin (PGI2) lowers heart rate in the conscious dog.
    Hintze TH; Panzenbeck MJ; Messina EJ; Kaley G
    Cardiovasc Res; 1981 Sep; 15(9):538-46. PubMed ID: 6797737
    [No Abstract]   [Full Text] [Related]  

  • 50. Preliminary investigation on the central action of prostacyclin (PGI2) in rats.
    Rajtar G; Kolasa K; Kleinrok Z
    Pol J Pharmacol Pharm; 1981; 33(6):627-32. PubMed ID: 6752913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does 15-hydroxy prostaglandin dehydrogenase contribute to prostaglandin inactivation in brain?
    Tse J; Coceani F
    Prostaglandins; 1979 Jan; 17(1):71-7. PubMed ID: 441426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin.
    Higgs GA; Salmon JA; Spayne JA
    Br J Pharmacol; 1981 Oct; 74(2):429-33. PubMed ID: 6274465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state.
    Hyman AL; Mathe AA; Leslie CA; Matthews CC; Bennett JT; Spannhake EW; Kadowitz PJ
    J Pharmacol Exp Ther; 1978 Nov; 207(2):388-401. PubMed ID: 361946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of reflex bradycardia and hypotension by metabolites of arachidonic acid in the cat.
    Hintze TH; Kaley G; Panzenbeck MJ
    Br J Pharmacol; 1984 May; 82(1):117-25. PubMed ID: 6375794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of lung transit on systemic depressor responses to arachidonic acid and prostacyclin in dogs.
    Waldman HM; Alter I; Kot PA; Rose JC; Ramwell PW
    J Pharmacol Exp Ther; 1978 Feb; 204(2):289-93. PubMed ID: 340641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of pyrogen and antipyretics on prostaglandin acitvity in cisternal c.s.f. of unanaesthetized cats.
    Feldberg W; Gupta KP; Milton AS; Wendlandt S
    J Physiol; 1973 Oct; 234(2):279-303. PubMed ID: 4588122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostacyclin, indomethacin and the cerebral circulation.
    Pickard J; Tamura A; Stewart M; McGeorge A; Fitch W
    Brain Res; 1980 Sep; 197(2):425-31. PubMed ID: 6773615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.